Video: Generative AI and the Future of Health Care, Part 2

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

A PDUFA date for acoramidis has been set for November 29, 2024.

From the Pharmacy of the Year winner announcement to a powerful Women in Pharmacy Workshop, here's what you missed on day 2 of ThoughtSpot.

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.